Sign Out
Pregnancy: Neonates exposed to antipsychotic drugs during the third trimester of pregnancy are at risk for extrapyramidal and/or withdrawal symptoms following delivery. There have been reports of agitation, hypertonia, hypotonia, tremor, somnolence, respiratory distress, and feeding disorder in these neonates. These complications have varied in severity; while in some cases symptoms have been self-limited, in other cases neonates have required intensive care unit support and prolonged hospitalization.
APALIFE should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.
Breastfeeding: Aripiprazole is excreted in human breast milk. Patients should be advised not to breast feed if they are taking Aripiprazole.
